San Francisco’s Forta, an AI healthcare innovator, recently secured $55 million in Series A funding. This financial boost, spearheaded by Insight Partners, a global software investor, is set to revolutionize the company’s approach to healthcare, particularly in autism therapy.
Breakthrough in AI-Driven Healthcare
Forta’s ambition is to transform the healthcare landscape by integrating artificial intelligence (AI) and Large Language Models (LLMs) into its operations. The primary goal is to enhance healthcare outcomes and make them more accessible to everyone. The recent funding will be pivotal in scaling up their unique family-powered autism therapy initiative, incorporating AI in applied behavior analysis (ABA) therapy.
Expanding Beyond Autism Therapy
Initially focusing on autism therapy due to extensive care wait times, Forta now plans to broaden its approach. The company is exploring ways to apply its empowered home caregiver model to other areas like memory care and chronic conditions.
The Series A funding is not just a means to expand the autism therapy practice but also fuels ongoing research in AI and LLMs. The aim is to discover innovative pathways that enhance care outcomes and accessibility. This financial round saw participation from significant tech and healthcare investors, including Exor Ventures and Alumni Ventures, and founders from notable companies such as 23&Me and Warby Parker.